A detailed history of Capital World Investors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital World Investors holds 13,954,017 shares of MRK stock, worth $1.75 Billion. This represents 0.31% of its overall portfolio holdings.

Number of Shares
13,954,017
Previous 8,326,094 67.59%
Holding current value
$1.75 Billion
Previous $908 Million 102.84%
% of portfolio
0.31%
Previous 0.17%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $637 Million - $743 Million
5,627,923 Added 67.59%
13,954,017 $1.84 Billion
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $331 Million - $360 Million
-3,302,748 Reduced 28.4%
8,326,094 $908 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $154 Million - $171 Million
-1,492,724 Reduced 11.38%
11,628,842 $1.2 Billion
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $132 Million - $144 Million
-1,212,628 Reduced 8.46%
13,121,566 $1.51 Billion
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $247 Million - $276 Million
2,399,262 Added 20.1%
14,334,194 $1.53 Billion
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $76.4 Million - $97.9 Million
-873,208 Reduced 6.82%
11,934,932 $1.32 Billion
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $24.9 Million - $28 Million
295,034 Added 2.36%
12,808,140 $1.1 Billion
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $50.5 Million - $57.2 Million
604,458 Added 5.08%
12,513,106 $1.14 Billion
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $12.2 Million - $13.7 Million
-166,267 Reduced 1.38%
11,908,648 $977 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $193 Million - $242 Million
2,675,538 Added 28.47%
12,074,915 $925 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $241 Million - $266 Million
3,368,622 Added 55.86%
9,399,377 $706 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $464 Million - $513 Million
-6,598,396 Reduced 52.25%
6,030,755 $469 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $537 Million - $632 Million
-7,797,252 Reduced 38.17%
12,629,151 $974 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $397 Million - $441 Million
-5,535,573 Reduced 21.32%
20,426,403 $1.67 Billion
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $549 Million - $623 Million
-7,505,176 Reduced 22.43%
25,961,976 $2.15 Billion
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $334 Million - $380 Million
-4,744,920 Reduced 12.42%
33,467,152 $2.59 Billion
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $1.49 Billion - $2.07 Billion
-23,575,625 Reduced 38.16%
38,212,072 $2.94 Billion
Q4 2019

Feb 18, 2020

SELL
$77.58 - $87.54 $1.45 Billion - $1.63 Billion
-18,671,795 Reduced 23.21%
61,787,697 $5.62 Billion
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $286 Million - $312 Million
-3,759,196 Reduced 4.46%
80,459,492 $6.77 Billion
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $373 Million - $436 Million
-5,346,246 Reduced 5.97%
84,218,688 $7.06 Billion
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $155 Million - $177 Million
-2,225,862 Reduced 2.42%
89,564,934 $7.45 Billion
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $293 Million - $340 Million
4,486,621 Added 5.14%
91,790,796 $7.01 Billion
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $1.02 Billion - $1.2 Billion
-17,693,498 Reduced 16.85%
87,304,175 $6.19 Billion
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $777 Million - $913 Million
15,288,378 Added 17.04%
104,997,673 $6.37 Billion
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $3.15 Million - $3.66 Million
61,820 Added 0.07%
89,709,295 $4.89 Billion
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $52.3 Million - $62.5 Million
1,013,496 Added 1.14%
89,647,475 $5.04 Billion
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $5.2 Billion - $5.6 Billion
88,633,979
88,633,979 $5.68 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $318B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.